Significance of Acellular Mucin Pools in Rectal Carcinoma After Neoadjuvant Chemoradiotherapy
Authors:
- Jinru ShiaJSJinru Shia
- Martine McManusMMMartine McManus
- Laura H. TangLTLaura H. Tang
- Konstantin Ma KolosovKKKonstantin Ma Kolosov
- 1 January 2011
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 35 (1) , 127-134
Abstract
The presence of mucin pools lacking neoplastic epithelium (“acellular” mucin) in resection specimens of rectal carcinoma after neoadjuvant chemoradiotherapy (CRT) is a well-recognized phenomenon. The current recommendation by the College of American Pathologists is to regard acellular mucin as a type of treatment response and not as residual tumor. However, data-based evidence for or against such an approach is incomplete. In this study, we systematically analyzed the pattern and significance of mucin pools in 108 consecutive, prospectively collected resection specimens from patients who had uT3-4 and/or uN1 rectal cancer and were treated with preoperative long-course CRT. The 108 patients, 39 female and 69 male, had a median age of 58.5 years. With every tumor entirely examined in whole-mount sections, mucin pools were identified in 33 cases (33 of 108, 31%); in 16 (15%) they were all acellular. The mucin pools were focal (10% to 50% of the entire lesion) in 25 cases and extensive (>50%) in 8 cases. Mucin pools were also noted in the lymph nodes in 6 cases (6%); 3 of these were entirely acellular. Five cases had mucin pools in both the primary site and the lymph nodes. When acellular mucin was considered as “no residual tumor,” the complete pathologic response rate for the entire cohort was 22% (24 of 108). The pathologic stage of the residual tumor (ypT) was 0 or 1 for 27 cases (25%) and 2 to 4 for 81 cases. The pathologic stage of nodal disease (ypN) was 0 for 83 (77%) and 1 or 2 for 25 cases. When acellular mucin was considered as “residual tumor,” the complete pathologic response rate dropped to 17%; ypT was upstaged in 10 tumors and ypN was upstaged in 2 tumors. With a median follow-up of 31 months, the 3-year recurrence-free survival (RFS) was 73% for the entire group. Advanced pathologic response and low pathologic stage of the residual tumor (determined based on the depth of only viable tumor cells) correlated significantly with better RFS. However, the correlation between pathologic response and RFS became insignificant when acellular mucin pools were considered as residual tumor. Neither the presence of mucin pools nor their extent or cellularity had an impact on RFS. Furthermore, none of the 12 patients whose ypT or ypN was upstaged by acellular mucin had recurrent disease (3-y RFS of 100%). Thus, our results suggest that mucin pools in rectal carcinoma after neoadjuvant CRT do not have a significant impact on patient outcome, supporting the College of American Pathologists recommendation that only viable tumor cells, not acellular mucin, are to be interpreted as residual disease in the tumor pathologic staging.Keywords
This publication has 13 references indexed in Scilit:
- Prevalence and Significance of Prominent Mucin Pools in the Esophagus Post Neoadjuvant Chemoradiotherapy for Barrett??s-Associated AdenocarcinomaAmerican Journal of Surgical Pathology, 2006
- Modern management of rectal cancer: A 2006 updateWorld Journal of Gastroenterology, 2006
- Impact of Colloid Response on Survival After Preoperative Radiotherapy in Locally Advanced Rectal CarcinomaAmerican Journal of Surgical Pathology, 2005
- Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviourThe Journal of Pathology, 2004
- Short‐term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancerThe Journal of Pathology, 2002
- Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancerDiseases of the Colon & Rectum, 1997
- Sphincter preservation with preoperative radiation therapy and coloanal anastomosisInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994
- Carcinoma of large intestine in patients irradiated for carcinoma of cervix and uterusCancer, 1973